Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The physical product is due to launch in Italy early next year followed by other countries, you would expect a early strike TO for a better deal as a buyer.
For us some of us expect a modest £2.50 upto a high past £5
I'm thinking that STEM will open at about 100p except there is often an uplift because its possibly going to be a hot stock with lots of news around its launch. Lots of people will point to the exact sciences purchase of 7 months ago Exact Sciences paid $2.8bn for a similar but inferior product. Part of that price was because there was already a sales and marketing support network in place for the product. STEM does not have this which is part of the reason for the £200m valuation for this. Except that if the buyer is a major then they will already have such a network. If you stick with a sale of about £2.8bn giving a slight premium because its a 40% superior product. TILS has about 200m shares in circulation which should mean a similar figure for STEM gives a valuation of £14 per share for STEM. But that would be in the long term. In the short term I can see 200-500p for STEM.
If it floats at a value of 200 million dollars and there are around 200 million shares that equates to approx a dollar a share. At current exchange rate that equates to about 80p. Market forces will give the company its initial valuation which may well be somewhat above this, I don't see it being less and I only see the price rising as it gets established.
If the new company has the same amount of shares as tils the sp would be £1.20 at an Mcap of 200 mill as that is what tils would be if it were 200 mill. As it happens we’re 336 mill which I think the new company will be very quickly and I believe with a bit of strategic news after the split tils won’t drop it will rise too.
I think £1.40 was muted but now we have additional shares in circulation with the fund raising this would be pro rata and a bit less
It will be what it will be and I for one am looking forward to it and Im keen on knowing who has invested the $57M at $5.20 a pop.
Looking forward to the future playing out
I thought it was about £1.17 per share at a £200m list price? Based on the amount of shares it would list with (not yet gone and checked the latest amount)
If Accustem floats with an estimated value of 200 million dollars. The first day of trading share price would be approx 80p. I would envisage this to rise as the company acquires market share.
I think £1 billion sale price would be about £5.86 per share from memory?
Agree the 200m is just the starting price should sell for at least 1 billion
GC stated it would list circa $200 million mcap
Does the accu in the name of the spin-off not hint that it is going to be bought by roche? Or am I just seeing a link that isn’t there?
They wont hold back the demerger. Accustem will most likely get a main market listing as is worthy of a product that is potentially worth in excess of $3 billion
Given the AIM MM's manipulating the price to get and keep it down despite buys outstripping sales is there any likelihood that the StemprintER split off waits until switchover to LSE so profits could be maximised for Tiziana as well as shareholders?
I'm certainly not deramping the stock - it's the biggest stockholding in my £15k portfolio - but am interested on people's thoughts seeing as many of you have so much more knowledge/experience of such things.
If they did hold it back for the switchover, what's the earliest StemprintER would then hit the market?